Utilize este identificador para referenciar este registo: http://hdl.handle.net/10451/45190
Título: Methimazole associated eosinophilic pleural effusion: a case report
Autor: Gaspar da Costa, Pedro
Duarte Silva, Filipa
Henriques, Júlia
Vale, Sónia do
Braz, Sandra
Meneses Santos, João
M.M. Victorino, Rui
Palavras-chave: Eosinophilic pleural effusion
Thionamides
Methimazole
Hypersensitivity reaction
Case report
Data: 2017
Editora: BioMed Central Ltd.
Citação: BMC Pharmacol Toxicol. 2017 Mar 21;18(1):16
Resumo: Background: Adverse reactions associated to anti-thyroid drugs include fever, rash, arthralgia, agranulocytosis and hepatitis that are thought to be hypersensitivity reactions. Five cases of pleural effusion associated to thionamides have also been reported, two with propylthiouracil and three with carbimazole. Case presentation: We report here a case of a 75-year-old man admitted because of unilateral pleural effusion. The patient had a recent diagnosis of hyperthyroidism and 6 days after starting methimazole complained of pleuritic chest pain. He had elevated C-reactive protein and erythrocyte sedimentation rate and normal white blood cell count and liver enzymes. Chest radiography showed a moderate right pleural effusion and the ultrasound revealed a loculated effusion that was shown to be an eosinophilic exudate. Conclusions: The temporal relationship between methimazole intake and the development of pleural effusion combined with the extensive exclusion of alternative causes, namely infectious, neoplastic and primary auto-immune diseases, led to the diagnosis of hypersensitivity reaction to methimazole. The thionamide was stopped and corticosteroid was started with complete resolution of the pleural effusion in 3 months. Awareness of this rare adverse reaction of anti-thyroid drugs is important and methimazole can be added to the list of possible etiologies of drug-induced eosinophilic pleural effusion.
Descrição: © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, andreproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link tothe Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Peer review: yes
URI: http://hdl.handle.net/10451/45190
DOI: 10.1186/s40360-017-0121-1
Versão do Editor: https://bmcpharmacoltoxicol.biomedcentral.com/
Aparece nas colecções:FM - Artigos em Revistas Internacionais

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
Methimazole.pdf347,75 kBAdobe PDFVer/Abrir


FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpace
Formato BibTex MendeleyEndnote 

Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.